Allergy Shots for Hay Fever: From Bostock 1819 to Cochrane 2007
Allergy shots for hay fever are SCIT for allergic rhinitis — hay fever is neither caused by hay nor a fever. John Bostock coined 'catarrhus aestivus' in 1819; the first immunotherapy protocol came from Leonard Noon's 1911 Lancet paper targeting grass pollen. Cochrane Calderón 2007 (51 RCTs, 2,871 patients): symptom SMD −0.73, medication SMD −0.57. Durham 1999 NEJM: 3 additional years of remission after a 3–4 year grass SCIT course.
7 peer-reviewed sources
Allergy shots for hay fever are SCIT for pollen-driven allergic rhinitis — the same treatment as seasonal allergy shots. Cochrane 51 RCTs: symptom SMD −0.73. The regimen dates to Noon's 1911 Lancet grass-pollen protocol.
The essentials
Allergy shots for hay fever are subcutaneous immunotherapy (SCIT) for allergic rhinitis — the clinical term for what lay language calls hay fever. The etymology clarifies the framing: hay fever is neither caused by hay nor a fever. The term was coined by John Bostock, who on March 16, 1819, presented "Case of a periodical affection of the eyes and chest" to the Medical and Chirurgical Society of London, describing his own annually recurrent catarrhal symptoms during summer. He later termed the condition catarrhus aestivus ("summer catarrh"). The "hay fever" name entered medical literature around 1828, originally tied to grass-pollen exposure during haying season. Today it covers allergic rhinitis driven by any seasonal pollen — tree, grass, or weed.
The immunotherapy for hay fever traces directly to grass pollen. Leonard Noon published "Prophylactic inoculation against hay fever" in the Lancet on June 17, 1911 (177:1572-1573) — the founding paper of modern SCIT. Noon injected subcutaneous doses of Timothy grass pollen extract at escalating concentrations in hay-fever patients, establishing the basic dose-escalation principle that governs SCIT to this day. The allergen has changed from crude extract to characterized major-allergen formulations over 113 years; the dose-escalation logic has not.
Curex's at-home IgE testing identifies which specific pollens — tree, grass, ragweed — drive a patient's hay fever, with allergist review to map them to the regional pollen calendar.
The modern evidence base: Cochrane Calderón 2007 synthesized 51 RCTs across 2,871 patients and found symptom SMD −0.73 (95% CI −0.97 to −0.50) and medication-use SMD −0.57 (95% CI −0.82 to −0.33) for seasonal allergic rhinitis. Walker 2001 JACI documented approximately 49% symptom-score and approximately 80% medication-score reduction in a grass SCIT RCT (P=.007). Durham 1999 NEJM established the disease-modification landmark: 3 years of sustained clinical benefit after stopping a 3–4 year grass SCIT course, with persistent allergen-specific IgG4 — a finding unmatched by any antihistamine or intranasal steroid.
Hay fever prevalence: approximately 19–25% of US adults have allergic rhinitis. NHANES 2005-2006 (Salo PM et al., JACI 2014;134:350-359) documented 44.6% of those ≥6 years having detectable IgE to at least one allergen. Quality-of-life impact of uncontrolled hay fever is substantial: RQLQ-validated between-group difference of 0.8 (95% CI 0.18–1.5) favoring SCIT in the Walker 2001 trial. The pediatric PAT study (Möller 2002 JACI, Jacobsen 2007 Allergy) halved asthma incidence at 10-year follow-up in children completing pollen SCIT — the most clinically impactful evidence for immunotherapy over lifetime pharmacotherapy.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Efficacy by allergen — what the data shows
Hay fever SCIT evidence is the oldest and deepest in the immunotherapy literature — from Noon's 1911 grass-pollen protocol to the 2007 Cochrane synthesis.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youFrequently asked questions
Why is it called hay fever if it isn't from hay and isn't a fever?
John Bostock, an English physician, first described the condition in 1819 and called it catarrhus aestivus (Latin for 'summer catarrh'). The popular term 'hay fever' emerged around 1828 and was associated with the haying season in England — when grass was cut and dried — during which sensitized patients experienced peak symptoms. The name stuck despite being etymologically inaccurate on both counts: grass pollen (not hay) is the trigger, and the condition produces rhinitis and conjunctivitis, not true fever. Modern clinical terminology is allergic rhinitis (AR) or seasonal allergic rhinoconjunctivitis. The Bostock 1819 original case is documented in: Ramachandran M, Aronson JK. John Bostock's first description of hayfever. J R Soc Med. 2011;104:237.
When were allergy shots first used for hay fever?
The first allergy shot for hay fever was administered by Leonard Noon and John Freeman at St. Mary's Hospital London, with Noon publishing 'Prophylactic inoculation against hay fever' in the Lancet on June 17, 1911 (177:1572-1573). Noon used subcutaneous injections of Timothy grass pollen extract at escalating doses in hay-fever patients, establishing the dose-escalation principle that governs modern SCIT. He died before completing his research; Freeman continued the work. The grass-pollen immunotherapy documented in Noon's paper is directly ancestral to the 2007 Cochrane meta-analysis confirming the same treatment 96 years later.
Are allergy shots the only disease-modifying treatment for hay fever?
SCIT and SLIT are the only available disease-modifying treatments for hay fever / pollen allergic rhinitis. Pharmacotherapy — second-generation antihistamines, intranasal corticosteroids — effectively controls symptoms while taken but has no lasting effect after discontinuation. Durham 1999 NEJM documented 3 additional years of clinical remission after stopping a 3–4 year grass SCIT course, with persistent allergen-specific IgG4. FDA-approved SLIT tablets (Grastek, Oralair, Ragwitek) share the same disease-modifying mechanism via daily sublingual delivery. No pharmacotherapy, biologic, or steroid injection produces comparable post-treatment remission.
How many visits does hay fever SCIT require?
Per Cox 2011 PP3, Year 1 of conventional clinic-based hay fever SCIT requires approximately 39 visits: 26–28 weekly build-up injections plus 13 early maintenance visits. Years 2–5 average approximately 14 visits per year; a 4-year course totals approximately 81 visits. Each visit includes a 30-minute post-injection observation window. Cluster schedules can compress Year-1 visit count to 7–13 visits (Tabar 2005). Adherence is the primary real-world barrier: Tkacz 2021 (n=103,207) found 23.9% of patients never returned for their second injection. Curex's at-home SCIT model replaces weekly clinic trips with a single weekly self-administered shot — the same visit-count schedule, just from home, with the first dose and every dose change supervised live over Zoom.
Can hay fever allergy shots prevent asthma?
In children with seasonal allergic rhinitis and no asthma, pollen SCIT has the strongest disease-prevention evidence in allergy medicine. The PAT study (Möller C et al., JACI 2002;109:251-256; Jacobsen L et al., Allergy 2007;62:943-948) randomized 205 children: at 10-year follow-up, 16/64 SCIT-treated children developed asthma versus 24/53 untreated controls, yielding an adjusted OR of 4.6 (95% CI 1.5–13.7) favoring asthma-free status in the SCIT group. No antihistamine or intranasal steroid produces a comparable preventive effect. This asthma-prevention benefit is the strongest pediatric argument for early SCIT intervention in hay-fever patients.
Are there allergy shots for both tree pollen and grass pollen hay fever together?
Yes — SCIT can address multiple simultaneous pollen sensitizations in a single vial. A patient with spring-tree and summer-grass hay fever would typically receive a multi-allergen vial containing both tree pollens (birch, oak, hickory as applicable) and grass mix (timothy, orchard, Kentucky bluegrass) — with short ragweed added if fall symptoms also occur. The extract is customized based on IgE testing results. The build-up schedule and maintenance regimen are the same regardless of how many pollen allergens are represented in the vial.
What are FDA-approved alternatives to hay fever allergy shots?
For three specific hay fever pollen allergens, FDA-approved SLIT tablets provide a non-injection disease-modifying option: Grastek (ALK, timothy grass, ages 5–65, FDA-approved 2014), Oralair (Stallergenes, 5-grass mix, ages 5–65, FDA-approved 2014), and Ragwitek (Merck, short ragweed, ages 5–65 after 2021 expansion). All three are daily sublingual tablets; all carry boxed warnings for anaphylaxis, require a supervised first dose, and require co-prescription of an epinephrine auto-injector. For tree pollen hay fever, no FDA-approved US SLIT tablet exists; SCIT or compounded SLIT drops are the disease-modifying options.
Related Articles
Ragweed Allergy Shots: Evidence & Options | Curex Guide
Ragweed SCIT: strongest US single-allergen RCT (Creticos 1996 NEJM). Ragwitek FDA-approved ages 5–65. Season extended to 10–12 wks. At-home shots: $129/mo.
Read moreAllergy Shot for Seasonal Allergies — Single Shot? | Curex
One allergy shot won't treat seasonal allergies — SCIT requires 60–80 injections over 3–5 years. A single IM steroid shot exists but is discouraged. Learn the real options.
Read moreMold Allergy Shots: Evidence & Limits | Curex Guide
Mold SCIT has one well-controlled RCT allergen — Alternaria (Kuna 2011: 63.5% reduction). Cladosporium, Aspergillus, Stachybotrys lack RCT support. Full honest guide.
Read moreAllergy Shots for Humans | Curex Complete SCIT Guide
Yes — allergy shots for humans exist. SCIT has Cochrane SMD −0.73, 51 RCTs, and 1 fatality per 23.3M visits. Not Cytopoint. Not Apoquel. Full guide with pet-allergen disambiguation.
Read moreAllergy Shots vs Drops: Evidence-Based Comparison | Curex
Allergy shots (SCIT) vs sublingual drops (SLIT): comparable efficacy per Nelson 2015, but SLIT has zero fatalities vs 1 per 2.5M shots. Full comparison.
Read moreAllergy Injection Name: SCIT Defined | Curex
The clinical name for an allergy injection is SCIT (subcutaneous immunotherapy). It has no brand name. Biologics, depot steroids, and epinephrine devices are branded — SCIT is not.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.